Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W2EX
|
|||
| Former ID |
DNC012963
|
|||
| Drug Name |
(S)-2-amino-4-(benzylthio)butanoic acid
|
|||
| Synonyms |
S-Benzyl-L-homocysteine; S-benzylhomocysteine; CHEMBL380911; 7689-60-3; (S)-2-amino-4-(benzylthio)butanoic acid; SCHEMBL2829688; S-(Phenylmethyl)-L-homocysteine; 2-Amino-4-benzylthiobutyric Acid; KIPDMPPOTUGMPW-JTQLQIEISA-N; ZINC2035154; BDBM50179713; NSC 206263; NSC 164657; L-2-Amino-4-(benzylthio)butyric Acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H15NO2S
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CSCCC(C(=O)O)N
|
|||
| InChI |
1S/C11H15NO2S/c12-10(11(13)14)6-7-15-8-9-4-2-1-3-5-9/h1-5,10H,6-8,12H2,(H,13,14)/t10-/m0/s1
|
|||
| InChIKey |
KIPDMPPOTUGMPW-JTQLQIEISA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Oxytocin signaling pathway | ||||
| Hypertrophic cardiomyopathy (HCM) | ||||
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ||||
| Dilated cardiomyopathy | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||
| WikiPathways | Arrhythmogenic Right Ventricular Cardiomyopathy | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.